International, multi-center, randomized, double-blind

Project: Research project

Project Details

Description

International, multi-center, randomized, double-blind, placebo-controlled phase III study assessing in parallel groups the efficacy and safety of 2 doses of PXT3003 in patients with Charcot-Marie-Tooth Disease type 1A treated 15 months
StatusFinished
Effective start/end date12/1/1511/30/19

Funding

  • PHARNEXT

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.